Skip to main content
. 2017 May 24;8(30):50305–50313. doi: 10.18632/oncotarget.18148

Figure 3. MRI and EGFR-18F-FDG and PET/CT scans in a male patient presented with glioblastoma multiforme at eight months following surgical resection.

Figure 3

A. and B. MRI scans demonstrating the tumor relapse at eight months following surgical resection. The white arrow shows the tumor hollowing. C. and D. EGFR-18F-FDG, PET/CT scans demonstrate heterogeneous tumor characteristics at 48 hours post-tracer injection, yellow arrows demonstrate area with lower staining intensity in the frontal lobe and the red arrow demonstrates a higher staining intensity in the temporal lobe. E. and F. CT scan indicating tumor hollowing and significant edema.